Core Scientific, Inc.
CORZ
$14.53
$0.402.83%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -40.66% | -28.48% | -9.04% | -9.63% | -34.21% |
Total Other Revenue | -39.10% | -26.30% | 4.72% | 25.07% | 30.24% |
Total Revenue | -39.43% | -26.76% | 1.65% | 15.77% | 8.25% |
Cost of Revenue | -20.44% | -10.61% | 0.40% | -10.69% | -24.75% |
Gross Profit | -84.24% | -64.11% | 5.46% | 334.62% | 3,167.78% |
SG&A Expenses | 80.50% | 64.82% | 32.30% | 6.56% | -21.90% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -522.46% | 215.27% | -76.26% | 1,105.78% | 241.76% |
Total Operating Expenses | -3.89% | 6.15% | 6.39% | -7.03% | -23.95% |
Operating Income | -334.76% | -279.75% | -212.02% | 139.56% | 142.98% |
Income Before Tax | -29.60% | -2,626.93% | -434.63% | -145.54% | 6.70% |
Income Tax Expenses | 9.00% | 9.30% | 25.77% | 103.88% | 107.54% |
Earnings from Continuing Operations | -29.58% | -2,568.90% | -433.50% | -156.39% | 5.49% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -29.58% | -2,568.90% | -433.50% | -156.39% | 5.49% |
EBIT | -334.76% | -279.75% | -212.02% | 139.56% | 142.98% |
EBITDA | -129.50% | -107.17% | -5.56% | 198.36% | 483.77% |
EPS Basic | 52.76% | -2,474.92% | -737.95% | -340.37% | -81.68% |
Normalized Basic EPS | 18.65% | -2,528.89% | -3,274.21% | -2,211.84% | -764.34% |
EPS Diluted | 54.32% | -5,133.05% | -750.41% | -351.25% | -87.67% |
Normalized Diluted EPS | 20.11% | -3,986.22% | -3,315.01% | -2,242.97% | -780.08% |
Average Basic Shares Outstanding | 4.66% | -20.52% | -33.62% | -29.50% | -22.23% |
Average Diluted Shares Outstanding | 0.26% | -23.39% | -30.23% | -26.15% | -18.82% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |